Bottom panel: Panel of oncogene-like lncRNAs and their signaling flow-through that affects malignancy characteristics (e. g., proliferation, de-differentiation, migration, invasion, angiogenesis EMT, CSC status) in NB cells, which dictates NB pathogenesis and disease evolution. Blue circles indicates the preclinically validated targeted therapeutic strategies for HR-NB.